Glutathione as a prognostic factor of health risk in working population
T.V. Blinova, L.A. Strakhova, V.V. Troshin, S.A. Kolesov, I.A. Umnyagina, J.V. Ivanova
Nizhny Novgorod Scientific Research Institute for Hygiene and Occupational Pathology, 20 Semashko Str., Nizhny Novgorod, 603105, Russian Federation
Redox balance plays the key role in maintaining health. Optimizing glutathione levels has been proposed as a strategy for health promotion and disease prevention, although cause-effect relationships between glutathione status and disease risk or treatment have not been fully clarified. This study aims to estimate glutathione as a non-specific prognostic risk factor of health disorders in people exposed to industrial aerosols at their workplaces. Our observation covered the following occupational groups: workers employed at a metallurgic plant who contacted industrial aerosols (welding and silicon-containing aerosols with predominantly fibrogenic effects); patients with non-obstructive chronic industrial bronchitis (NCIB) without exacerbation; patients suffering from occupational chronic obstructive pulmonary disease (oCOPD) who were in a post-exposure period; workers who were not exposed to industrial aerosols at their workplaces. Total glutathione (TG), reduced glutathione (GSH) and oxidized glutathione (GSSG) were identified in whole blood by the Ellman method.
Elevated GSSG levels (higher than 100 µmol/l) and low values of the GSH/GSSG ratio (less than 10 units) were identified in more than 50 % of the workers exposed to industrial aerosols. These markers were established to have diagnostic sensitivity of more than 50 %, diagnostic specificity of more than 85 % and prognostic significance of more than 80 % for the examined groups. The GSSG level and GSH/GSSG ratio can be used as a prognostic indicator of health disorders in workers exposed to industrial aerosols and a possibility of chronic bronchopulmonary pathology developing in future.
- Izmerov N.F., Bukhtiyarov I.V., Prokopenko L.V. Implementation concept of the state policy aimed at preserving health of Russia working population up to the year 2020 and beyond. ZNiSO, 2014, no. 9 (258), pp. 4–7 (in Russian).
- Schafer F.Q., Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfi de/ glutathione couple. Free Radic. Biol. Med., 2001, vol. 30, no. 11, pp. 1191–1212. DOI: 10.1016/s0891-5849(01)00480-4
- Peoples J.N., Saraf A., Ghazal N., Pham T.T., Kwong J.Q. Mitochondrial dysfunction and oxidative stress in heart disease. Exp. Mol. Med., 2019, vol. 51, no. 12, pp. 1–13. DOI: 10.1038/s12276-019-0355-7
- Babak O.Ya. Glutation v norme i pri patologii: biologicheskaya rol’ i vozmozhnosti klinicheskogo primeneniya [Glutathione in health and pathology: biological role and possibilities of clinical application]. Zdorov’e Ukrainy, 2015, no. 1, pp. 1–3 (in Russian).
- Janssen-Heininger Y.M.W., Nolin J.D., Hoffman S.M., van der Velden J.L., Tully J.E., Lahue K.G., Abdalla S.T., Chapman D.G. [et al.]. Emerging mechanisms of glutathione-dependent chemistry in biology and disease. J. Cell. Biochem., 2013, vol. 114, no. 9, pp. 1962–1968. DOI: 10.1002/jcb.24551
- Shahid S.U., Shabana, Humphries S. The SNP rs10911021 is associated with oxidative stress in coronary heart disease patients from Pakistan. Lipids Health Dis., 2018, vol. 17, no. 1, pp. 6. DOI: 10.1186/s12944-017-0654-8
- Lagman M., Ly J., Saing T., Singh M.K., Tudela E.V., Morris D., Chi P.-T., Ochoa C. [et al.]. Investigating the causes for decreased levels of glutathione in individuals with type II diabetes. PLoS One, 2015, vol. 10, no. 3, pp. e0118436. DOI: 10.1371/journal.pone.0118436
- Chaves F.J., Mansego M.L., Blesa S., Gonzalez-Albert V., Jiménez J., Tormos M.C., Espinosa O., Giner V. [et al.]. Inadequate cytoplasmic antioxidant enzymes response contributes to the oxidative stress in human hypertension. Am. J. Hypertens., 2007, vol. 20, no. 1, pp. 62–69. DOI: 10.1016/j.amjhyper.2006.06.006
- Iskusnykh I.Y., Zakharova A.A., Pathak D. Glutathione in Brain Disorders and Aging. Molecules, 2022, vol. 27, no. 1, pp. 324. DOI: 10.3390/molecules27010324
- Sotgia S., Fois A.G., Paliogiannis P., Carru C., Mangoni A.A., Zinellu A. Methodological fallacies in the determination of serum/plasma Glutathione limit its translational potential in chronic obstructive pulmonary disease. Molecules, 2021, vol. 26, no. 6, pp. 1572. DOI: 10.3390/molecules26061572
- Kodama Y., Kishimoto Y., Muramatsu Y., Tatebe J., Yamamoto Y., Hirota N., Itoigawa Y., Atsuta R. [et al.]. Antiox-idant nutrients in plasma of Japanese patients with chronic obstructive pulmonary disease, asthma-COPD overlap syndrome and bronchial asthma. Clin. Respir. J., 2017, vol. 11, no. 6, pp. 915–924. DOI: 10.1111/crj.12436
- Minich D.M., Brown B.I. A Review of Dietary (Phyto)Nutrients for Glutathione Support. Nutrients, 2019, vol. 11, no. 9, pp. 2073. DOI: 10.3390/nu11092073
- Sotgia S., Paliogiannis P., Sotgiu E., Mellino S., Zinellu E., Fois A.G., Pirina P., Carru C. [et al.]. Systematic review and meta-analysis of the blood glutathione redox state in chronic obstructive pulmonary disease. Antioxidants (Basel), 2020, vol. 9, no. 11, pp. 1146. DOI: 10.3390/antiox9111146
- Brigelius-Flohe R., Flohe L. Regulatory phenomena in the glutathione peroxidase superfamily. Antioxid. Redox Signal., 2020, vol. 33, no. 7, pp. 498–516. DOI: 10.1089/ars.2019.7905
- Wang L., Ahn Y.J., Asmis R. Sexual dimorphism in glutathione metabolism and glutathione-dependent responses. Redox Biol., 2020, vol. 31, pp. 101410. DOI: 10.1016/j.redox.2019.101410
- Wu W., Doreswamy V., Diaz-Sanchez D., Samet J.M., Kesic M., Dailey L., Zhang W., Jaspers I., Peden D.B. GSTM1 modulation of IL-8 expression in human bronchial epithelial cells exposed to ozone. Free Radic. Biol. Med., 2011, vol. 51, no. 2, pp. 522–529. DOI: 10.1016/j.freeradbiomed.2011.05.006
- Xie X., He Z., Chen N., Tang Z., Wang Q., Cai Y. The roles of environmental factors in regulation of oxidative stress in plant. Biomed Res. Int., 2019, vol. 2019, pp. 9732325. DOI: 10.1155/2019/9732325
- Münzel T., Schmidt F.P., Steven S., Herzog J., Daiber A., Sørensen M. Environmental noise and the cardiovascular system. J. Am. Coll. Cardiol., 2018, vol. 71, no. 6, pp. 688–697. DOI: 10.1016/j.jacc.2017.12.015
- Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (2021 report). Global Initiative for Chronic Obstructive Lung Disease (GOLD 2021). Available at: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25... (October 30, 2022).
- Chuchalin A.G., Avdeev S.N., Aisanov Z.R., Belevskiy A.S., Leshchenko I.V., Ovcharenko S.I., Shmelev E.I. Federal guidelines on diagnosis and treatment of chronic obstructive pulmonary disease. Pul’monologiya, 2022, vol. 32, no. 3, pp. 356–392. DOI: 10.18093/0869-0189-2022-32-3-356-392 (in Russian).
- Giustarini D., Fanti P., Sparatore A., Matteucci E., Rossi R. Anethole dithiolethione lowers the homocysteine and raises the glutathone levels in solid tissues and plasma of rats: a novel non-vitamin homocysteine-lowering agent. Biochem. Pharmacol., 2014, vol. 89, no. 2, pp. 246–254. DOI: 10.1016/j.bcp.2014.03.005
- Ballatori N., Krance S.M., Notenboom S., Shi S., Tieu K., Hammond C.L. Glutathione dysregulation and the etiology and progression of human diseases. Biol. Chem., 2009, vol. 390, no. 3, pp. 191–214. DOI: 10.1515/BC.2009.033
- Borisenok O.A., Bushma M.I., Basalai O.N., Radkovec A.Y. Glutathione biological role. Meditsinskie novosti, 2019, no. 7 (298), pp. 3–8 (in Russian).
- Franco R., Schoneveld O.J., Pappa A., Panayiotidis M.I. The central role of glutathione in the pathophysiology of human diseases. Arch. Physiol. Biochem., 2007, vol. 113, no. 4–5, pp. 234–258. DOI: 10.1080/13813450701661198